ABSTRACT OBJECTIVES This study sought to investigate sex-related differences in treatment and outcomes in elderly patients with non-ST-segment elevation acute coronary syndromes (NSTEACS).
The aim of the present study was to investigate sex-related differences in the pooled populations of the study. To investigate the sex effect on the primary endpoint in the trial and registry population, we pooled all data using a meta-analytical approach, assuming a series of different treatment effects because of different baseline characteristics. We applied the random-effects model to account for the variance within each population and between trial and registry. Survival plots and log rank tests were used to determine and compare the 1-year cumulative risk of events according to sex and age. The independent predictors of the 1-year primary composite endpoint were evaluated using the Cox proportional hazards model. The rates of overall and cardiovascular death, MI, stroke, and severe bleeding were also similar between sexes at 1-year follow-up, but the rate of rehospitalization for cardiovascular causes was Women enrolled in the registry had worse risk profiles compared with women enrolled in the trial, with significantly older age, lower estimated glomerular filtration rate, and higher rates of increased troponin levels and of ischemic ECG changes ( Table 2) . Coronary angiography was performed in 55% of women in both the trial and registry; however, the rate of revascularization was lower in the registry (33.3% vs. 41.4%; p ¼ 0.15). Clinical outcomes were similar between trial and registry populations both inhospital and at 1 year ( Table 2) . 
METHODS

REVASCULARIZATION VERSUS NONREVASCULARIZATION.
When comparing the 111 women who underwent any kind of coronary revascularization during the index admission with the 190 women who were not revascularized, the latter had a significantly worse risk profile, including older age and lower estimated glomerular filtration rate ( Table 3) . Inhospital mortality was significantly higher among nonrevascularized women (8.5% vs. 2.7%; p ¼ 0.05), whereas the MI rate was higher in the revascularized group (2.7% vs. 1.6%; p ¼ 0.51) ( Table 3 ). There were only 1 severe bleeding event and 1 stroke, and both occurred in the nonrevascularized group. At 1-year follow-up, nonrevascularized women had a 3-fold higher mortality rate (21.6% vs. 8.1%; p ¼ 0.002), mainly cardiovascular (17.3% vs. 6.3%; p ¼ 0.002). No Chart shows the unadjusted risk ratio and 95% confidence interval (CI) according to sex. The populations of the trial and registry did not show significant heterogeneity.
FIGURE 2 Kaplan-Meier Survival Curves for the Primary Endpoint Stratified by Sex
Kaplan-Meier survival curves for the primary endpoint (death, myocardial infarction, disabling stroke, and repeat hospitalization for cardiovascular causes or bleeding) in women versus men. significant differences were observed concerning other adverse events.
DISCUSSION
The main findings of the present study are the following: 1) when sex-related difference in age is eliminated by inclusion criterion, the baseline clinical characteristics are remarkably similar between sexes, including renal function, diabetes, ischemic ECG changes, and troponin levels, whereas a significantly lower ejection fraction in men probably reflects a longer ischemic history, with previous revascularizations; 2) despite these similarities, coronary revascularization is still significantly performed less in women; 3) the rate of in-hospital adverse events is similar between sexes; 4) the 1-year outcome was significantly worse in men, driven by a higher rate of cardiac rehospitalizations (mainly congestive heart failure); and 5) women who are not revascularized have a 3-fold higher in-hospital and 1-year mortality rate compared with revascularized women.
PATIENT POPULATION. The Italian Elderly ACS study included one of the largest prospectively enrolled populations of truly elderly ACS patients (6,7), with a very low heterogeneity between trial and registry.
In the pooled population, women underwent significantly fewer revascularizations compared with men; this difference derives from a slightly lower rate of coronary angiography, but also from a lower rate of revascularization after angiography. Notably, the rates of in-hospital adverse events were similar between sexes. This finding is in contrast with previous reports of higher in-hospital mortality and morbidity in women older than 75 years of age undergoing primary percutaneous coronary intervention (PCI) (8) . In the broader setting of NSTEACS, our study shows a similar short-term outcome between sexes and an even better 1-year clinical outcome in women, questioning the idea that elderly women may be too fragile to tolerate an invasive therapeutic approach. In fact, in a recent report describing age-specific sex differences in in-hospital mortality after an ACS, mortality difference by sex decreased with age, with women having marginally better outcomes at 70 years of age and older in NSTEMI (9) . Similarly, no sex difference in 1-year mortality was observed in the older age group of a large population of primary PCI patients (10). A possible explanation for these findings may be the longer history of coronary disease in elderly men compared with women, as also shown in our study.
A surprising finding in our study was the low rate of in-hospital severe bleeding in women. We believe Values are mean AE SD or n (%). *The sum of events does not add up to the total because of nonhierarchical reporting.
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that the use of the radial artery access in more than 70% of the patients may explain such a finding, at variance with former studies describing female sex as a risk factor for bleeding in ACS (11) and for PCI (12) , although such a sex-related risk decreased over the past years. Our study is in agreement with the Acute Coronary Syndrome Prospective Audit (ACACIA) registry, in which age 75 years and older was not a risk factor for bleeding (13) .
As expected, women enrolled in the registry showed a significantly worse profile compared with women enrolled in the trial. However, the rates of coronary angiography and revascularization did not differ significantly between trial and registry. Moreover, the prevalence of in-hospital and 1-year adverse events was comparable between groups, showing that the Italian ACS Elderly RCT did not enroll a low-risk population.
REVASCULARIZATION VERSUS NO REVASCULARIZATION.
Large NSTEACS registries showed that patients older than 75 years of age are less likely to receive an early invasive strategy and be revascularized, although their absolute accrued benefit appears to be the highest (6, 13) . In particular, in the ACACIA, only 30% of elderly patients underwent revascularization. In the present study, the rates of coronary angiography and revascularization are the highest reported in the literature for elderly patients, being 56% and 37% in women and 62% and 45% in men, respectively. This 
WHAT IS NEW?
In a large population of elderly NSTEACS patients, we observed that women had a short-term outcome similar to that in men and a better 1-year clinical outcome.
Revascularization in women was associated with markedly lower early and late mortality.
WHAT IS NEXT?
Elderly women with an NSTEACS should receive the same diagnostic and therapeutic approach as men.
